Your browser doesn't support javascript.
loading
Towards elimination of cervical cancer - human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries.
Ong, Sok King; Abe, Sarah K; Thilagaratnam, Shyamala; Haruyama, Rei; Pathak, Ruchi; Jayasekara, Harindra; Togawa, Kayo; Bhandari, Aliza K C; Shankar, Abhishek; Nessa, Ashrafun; Jugder, Uranbolor; Agustina, Julyanti; Biglari, Mohammed; Yusuf, Aasim; Tshomo, Ugyen; Fernando, Eshani; Cairo, Clarito; Kaung, Kyaw Kan; Rath, Beauta; Vongdala, Champadeng; Pradhananga, Kishore Kumar; Kim, Jeongseon; Chung, Youn Kyung; Thanh Huong, Tran Thi; Sangrajran, Suleeporn; Zhang, Yawei; Basu, Partha; Woo, Yin Ling; Sukumaran, Babu; Hwang, William Y K.
Afiliação
  • Ong SK; PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Brunei Darussalam.
  • Abe SK; National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Thilagaratnam S; Health Promotion Board, Singapore.
  • Haruyama R; Bureau of International Health Cooperation, National Center for Global Health and Medicine, Japan.
  • Pathak R; Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, India.
  • Jayasekara H; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Togawa K; National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Bhandari AKC; National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Shankar A; Department of Radiation Oncology, Dr B R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Delhi, India.
  • Nessa A; Department of Gynaecological Oncology, Bangabandhu Sheikh Mujib Medical University, Bangladesh.
  • Jugder U; Cancer Registry-surveillance and Early Detection Division, National Cancer Center of Mongolia, Ulaanbaatar, Mongolia.
  • Agustina J; National Cancer Center Indonesia, Dharmais Cancer Hospital, Jakarta, Indonesia.
  • Biglari M; Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Yusuf A; Shaukat Khanum Memorial Cancer Hospital and Research Centres, Lahore and Peshawar, Pakistan.
  • Tshomo U; Jigme Dorji Wangchuck National Referral Hospital, Bhutan.
  • Fernando E; National Cancer Control Programme, Ministry of Health, Sri Lanka.
  • Cairo C; Department of Health, Disease Prevention and Control Bureau, Manila, Philippines.
  • Kaung KK; Department of Public Health, Ministry of Health, Naypyidaw, Myanmar.
  • Rath B; Calmette Hospital, Phnom Penh, Cambodia.
  • Vongdala C; Cancer Center, Mittaphab Hospital, Vientiane, Lao PDR.
  • Pradhananga KK; Kathmandu Cancer Center Hospital, Tathali, Bhaktapur, Nepal.
  • Kim J; National Cancer Center Korea, Goyang, Republic of Korea.
  • Chung YK; National Cancer Center Korea, Goyang, Republic of Korea.
  • Thanh Huong TT; Vietnam National Cancer Institute & Hanoi Medical University, Hanoi, Vietnam.
  • Sangrajran S; National Cancer Institute, Bangkok, Thailand.
  • Zhang Y; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Basu P; International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Woo YL; University of Malaya & ROSE Foundation, Kuala Lumpur, Malaysia.
  • Sukumaran B; The Brunei Cancer Center, PJSC, Brunei Darussalam.
  • Hwang WYK; National Cancer Centre & Duke-NUS Medical School, Singapore.
Lancet Reg Health West Pac ; 39: 100860, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37576906
About 95% of cervical cancers worldwide are caused by human papillomavirus (HPV). Cervical cancer is preventable and curable if it is detected and treated early. We reviewed the latest national cervical cancer indicators, and barriers to HPV vaccination and cervical cancer screening in 21 Asian National Cancer Centers Alliance (ANCCA) member countries. Half (n = 11, 52%) of the countries have introduced HPV vaccination for girls as part of their national vaccination programme, three countries reported coverage of over 90%. Most ANCCA member countries have cervical cancer screening programmes, only five countries reported screening uptake of over 50%. The barriers to HPV vaccination coverage and cervical cancer screening participation have been identified. Ensuring health service accessibility and affordability for women, addressing sociocultural barriers, and strengthening the healthcare system and continuum of care are essential to increase HPV vaccination and cervical cancer screening coverage.
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Lancet Reg Health West Pac Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Lancet Reg Health West Pac Ano de publicação: 2023 Tipo de documento: Article